Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114539198B reveals novel Pd-catalyzed route. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing processes globally.
Novel reductive aminocarbonylation route using nitroarenes offers high yields and simplified purification for complex pharmaceutical intermediates.
Patent CN119161318A reveals a novel Pd-catalyzed route for benzopyran amides. Offers sustainable manufacturing, reduced waste, and reliable supply chain solutions for global pharmaceutical intermediates.
Patent CN102746077B reveals a green iodine-catalyzed route for amide synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101863954A details a high-yield 6-step route for N-tert-butyl-4-aza-5 alpha-androstane-3-ketone-17 beta-formamide, offering cost reduction in API manufacturing.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114539198B reveals a novel Pd-catalyzed route offering significant supply chain stability and cost reduction benefits for high-purity pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation method offers high efficiency and substantial cost reduction for pharmaceutical intermediate manufacturing supply chains globally for strategic business partners.
Innovative palladium-catalyzed method enables efficient pyrone derivative production with simplified process and enhanced supply chain reliability for pharma intermediates.
Innovative palladium-catalyzed method using nitroarenes as nitrogen source enables scalable production of chroman amide intermediates with high purity and simplified supply chain for pharmaceutical manufacturing.
Patent CN114539198B enables efficient synthesis of high-purity amide intermediates with streamlined process reducing lead time and manufacturing costs.
Patent CN114539198B enables high-purity API intermediates through innovative reductive aminocarbonylation, reducing supply chain complexity and manufacturing costs.
Patent CN113861086B enables high-yield synthesis of complex intermediates with simplified process and reduced environmental impact, ensuring reliable pharmaceutical supply chains.
Patent CN117164544A enables efficient pyrone synthesis using nitroarenes and molybdenum carbonyl, reducing costs and lead times for high-purity API intermediates.
Recent patent literature demonstrates a one-step palladium-catalyzed synthesis of benzofuran-3-carboxamide API intermediates, enabling high-purity production with cost reduction in API manufacturing and reliable supply.
Discover how reductive aminocarbonylation with molybdenum carbonyl reduces raw material costs by 30-40% for (hetero)chroman amide synthesis. Scale-ready for API manufacturing.
Discover a one-step palladium-catalyzed method for benzofuran-3-carboxamide synthesis. Achieve high efficiency, broad substrate tolerance, and simplified post-processing to reduce production costs and supply chain risks.
Solve indole carboxamide synthesis challenges with cobalt-catalyzed C-H activation. Achieve high yields, low cost, and scalable production for pharmaceutical intermediates.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Discover efficient one-step synthesis of benzofuran-3-carboxamide with high functional group tolerance. Reduce production costs and supply chain risks for pharmaceutical intermediates.